Big Buttons

• PCAC to discuss 503A bulks list substances

  FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.  read more →

• Next APC regional meeting: Seattle

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Seattle area October 3. read more →

• Don’t skip EduCon’s final (fantastic) session(s)

  The final session of this year’s EduCon is coming up in just a few weeks, and it’s a special double helping of legal goodness. read more →

• Welcome, new PFMs!

  We’ve added 31 Pharmacy-Facility Members since February! read more →

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

More News

Upcoming Events

September 17: APC Annual Meeting, Washington, DC

September 17-18: Compounders on Capitol Hill (CCH), Washington, DC

September 23: EduCon Virtual Learning Series, Part III

October 3: APC CompoundED UpDATE: A Regional Gathering, Renton, WA

October 22: APC Briefing: Coverage, Claims, and Compounding: What You Need to Know About Your Liability Insurance

October 25: APC CompoundED UpDATE: A Regional Gathering, Columbus, OH (registration link coming soon)

November 15-17: Personalized Medicine Certification Course 1: Endocrinology in St. Pete Beach, Fla.

December 13-15: A4M Longevity Fest, Las Vegas

The Latest Resources for Compounders

• Best Practices for Compounding Shortage Drugs
• Best Practices for Compounding Ketamine
• Best Practices for Clinic Direct Billing (Office Pay)
• Statement on Peptide Compounding
• Statement on Constructive Transfer

Click here for more resources for compounding professionals

APC In the News

A quick quote from Scott in WaPo:

The Washington Post's story "Eli Lilly ramps up its fight against imitation weight-loss drugs" contains a short quote from CEO Scott Brunner.

Inside Health Policy quotes Scott (again):

In its article on Lilly's introduction of DTC discounted vials of Zepbound, IHP included a great quote from CEO Scott Brunner.

Scott on Lilly on GLP-1s on CBS:

You’ve probably seen the news that Eli Lilly will begin selling Zepbound in vials by mail. What you may have missed is that the CBS News story quoted APC CEO Scott Brunner.

We gave background to Inside Health Policy:

Inside Health Policy used APC for information in its piece “Uncertainty Looms Over Bulk Production Of Personalized GLP-1 Drugs.”

Inside Health Policy covers our comment:

Our comment to FDA about its use of the Pharmacy Compounding Advisory Committee (PCAC) was covered in detail by Inside Health Policy.

Masoud on ABC News:

APC member Masoud Rashidi did a great job defending compounding on ABC News.

Joe Navarra on NBC Nightly News:

The story this past Monday is one of the best media reports on compounding we’ve seen.

Support Compounding

Our Patrons